Venous Thromboembolism in Elderly High-risk Medical Patients: Time Course of Events and Influence of Risk Factors
Overview
Affiliations
Venous thromboembolism (VTE) causes significant morbidity and mortality in hospitalized medical populations; however, medical patients do not currently receive thromboprophylaxis beyond their hospital stay. We reviewed the real-life occurrence of VTE-related care for 100 days post-hospitalization in Calgary, Canada. Using medical visit records with a unique patient identifier number applied throughout the city's hospitals, 989 high-risk patients were selected for review. Almost three-quarters of the elderly patients received appropriate prophylaxis while in hospital, and only 2% received prophylaxis on discharge. Over the 100-day follow-up, 21% of the patients presented with clinically suspected VTE, of which 3.8% had confirmed VTE. Patients with multiple risk factors (≥ 3) had the highest frequency of confirmed VTE (≥ 6.1%). This study suggests that the actual rate of VTE-related follow-up care in patients post-hospitalization is high in the first 100 days, particularly among those who have multiple risk factors, warranting consideration of extended thromboprophylaxis in this population.
Spyropoulos A, Goldin M, Ageno W, Albers G, Elliott C, Hiatt W TH Open. 2022; 6(3):e177-e183.
PMID: 36046208 PMC: 9273326. DOI: 10.1055/s-0042-1750379.
Challenges of extended venous thromboembolism prophylaxis in medical and surgical patients.
Chindamo M, Paiva E, do Carmo Jr P, Rocha A, Marques M J Vasc Bras. 2022; 21:e20210195.
PMID: 35836745 PMC: 9250351. DOI: 10.1590/1677-5449.202101951.
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics.
Mangiafico M, Caff A, Costanzo L J Clin Med. 2022; 11(11).
PMID: 35683485 PMC: 9180990. DOI: 10.3390/jcm11113099.
Bruno X, Koh I, Lutsey P, Walker R, Roetker N, Wilkinson K J Thromb Haemost. 2022; 20(7):1645-1652.
PMID: 35426248 PMC: 9247009. DOI: 10.1111/jth.15729.
Rungjirajittranon T, Owattanapanich W, Leelakanok N, Sasijareonrat N, Suwanawiboon B, Chinthammitr Y Clin Appl Thromb Hemost. 2021; 27:10760296211069082.
PMID: 34907791 PMC: 8689619. DOI: 10.1177/10760296211069082.